Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis and Comparison With Healthy Volunteers Carlos Bonilla2022-08-08T17:00:58-04:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-Associated Mechanisms of Action Carlos Bonilla2022-08-08T17:01:39-04:00Resources| Read More
Selective Induction of Activated Regulatory T-Cells in Healthy Volunteers by NKTR-358, a Novel IL-2 Conjugate Treg Stimulator, in Development for the Treatment of Autoimmune Diseases Carlos Bonilla2022-08-08T17:05:53-04:00Resources| Read More
Evidence of Target Engagement and Modulation: Biomarker Analysis of the Phase 1b Inhaled Seralutinib Study Carlos Bonilla2022-08-08T17:08:56-04:00Resources| Read More
